Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hodgkin Disease × Omeprazole × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Breast Neoplasms 6 Lymphoma, B-Cell, Marginal Zone 4 Barrett Esophagus 4 Lymphoma, Large B-Cell, Diffuse 3 Inflammation 3 Head and Neck Neoplasms 3 Zollinger-Ellison Syndrome 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Pancreatic Neoplasms 2 Lymphoma 2 Colorectal Neoplasms 2 Uterine Cervical Dysplasia 1 Triple Negative Breast Neoplasms 1 Stomach Ulcer 1 Solid Tumours 1 Solid Tumor 1 Prostatic Neoplasms, Castration-Resistant 1 Prostatic Neoplasms 1 Precancerous Gastric Lesions 1 Pharmacokinetics of MDV3100 1 Peripheral Nervous System Diseases 1 Ovarian Neoplasms 1 Obesity 1 Mouth Neoplasms 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Anaplastic 1

Interventions

Cyclophosphamide 179 fludarabine phosphate 105 Etoposide 100 Peripheral Blood Stem Cell Transplantation 90 Filgrastim 82 Mycophenolic Acid 80 Doxorubicin 78 Whole-Body Irradiation 73 Melphalan 73 Radiotherapy 68 Brentuximab Vedotin 68 Tacrolimus 66 fludarabine 63 Busulfan 63 Vinblastine 59 Cyclosporine 58 Rituximab 56 Dacarbazine 49 Gemcitabine 48 Granulocyte Colony-Stimulating Factor 47 Bleomycin 47 Vincristine 43 Antilymphocyte Serum 43 Prednisone 41 Nivolumab 40 Cytarabine 40 Methotrexate 39 Carmustine 34 pembrolizumab 31 Sirolimus 27

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06383338 2025-09-08

PEGASUS

Murdoch Childrens Research Institute

Phase 1 Recruiting

Hodgkin Disease, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon ⚡